Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Comparison of questionnaire scores among genotypes for the significant associations. by Dai Nogimura (21445649)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Sudden change from skewed distributions. by Ariel Burman (20329776)

Time and spatial sensitivity to process changes. by Ariel Burman (20329776)

Dam and pup body and brain weights. by Adrienne J. Bradley (20861948)

Subjects:

Reagent list. by Adrienne J. Bradley (20861948)

Subjects:

Increased Iba-1 in mouse pups exposed to Pg-OMV during pregnancy. by Adrienne J. Bradley (20861948)

Subjects:

ELISA and RT-qPCR evaluation of cytokines in the embryonic mouse brain. by Adrienne J. Bradley (20861948)

Subjects:

Differences in total Tau and p-Tau Thr231 following maternal Pg-OMV exposure. by Adrienne J. Bradley (20861948)

Subjects:

RT-qPCR evaluation of MYD88, NLRP3, and NFκβ in GA 18.5 pup brains. by Adrienne J. Bradley (20861948)

Subjects:

Modified intensity and location of cortical layer marker proteins following Pg-OMV exposure <i>in utero.</i> by Adrienne J. Bradley (20861948)

Subjects:

Data for figures. by Adrienne J. Bradley (20861948)

Subjects:

Allometric of beds number allometric types and their changes in YRD Cities, 2009–2022. by Deng Jing (20614820)

Allometric of doctors, number of allometric types and their changes in YRD Cities, 2009–2022. by Deng Jing (20614820)

Land-use change in Quetta from (a) 1992, (b) 2002, (c) 2013 and (d) 2022. by Naveed Ahmed (2433958)

“…It is evident from the results that barren land in Quetta increased in 2022, whereas build-up area significantly decreased, as shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317342#pone.0317342.g006" target="_blank">Fig 6</a>. …”

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-t... by Emir Matpan (21655811)

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)